Search results
Results from the WOW.Com Content Network
Scleritis is a serious inflammatory disease that affects the white outer coating of the eye, known as the sclera. The disease is often contracted through association with other diseases of the body, such as granulomatosis with polyangiitis or rheumatoid arthritis .
These findings inform potential impairments that may be seen during the second part of the FEES protocol. The second part of the FEES protocol involves food, or "bolus" presentation to observe swallow function. [9] Food coloring is typically given in the food to track the food as it travels along the natural pink-colored tissues of the throat ...
If there is an underlying cause, treatment should be given based on the disease. Non specific treatment measures include cycloplegics , corticosteroids and immunosuppressive drugs . [ 2 ] The biologic drugs that are currently used in treatment of panuveitis include anti tumor necrosis factor , cytokine receptor antibodies and interferon-α .
Episcleritis is a benign, self-limiting condition, meaning patients recover without any treatment. Most cases of episcleritis resolve within 7–10 days. [2] The nodular type is more aggressive and takes longer to resolve. [2] Although rare, some cases may progress to scleritis. [13]
Declining due to improved treatment of strep throat [30] Kawasaki disease: Coronary arteries: Unknown Probable 20 per 100,000 children under age 5 [31] Giant cell arteritis: Large and medium arteries, can affect coronary arteries None specific Confirmed 200 per 100,000 (over age 50) [32] [33] Takayasu's arteritis: Large arteries, including the ...
President Joe Biden signed the Social Security Fairness Act into law Sunday afternoon, marking what is expected to be one of the last major pieces of legislation of his presidency. Prior to ...
Health officials in Europe are investigating Ozempic and the trendy drug’s possible link to an eye-rotting condition that causes blindness. On Dec. 17, the European Medicines Agency announced ...
The former CEO of Abercrombie & Fitch (A&F) has dementia and late onset Alzheimer's disease, his legal team has said in a court document filed in New York. Lawyers for Mike Jeffries have requested ...